TCI Wealth Advisors, Inc. - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 77 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$4,000
-96.0%
171
-97.5%
0.00%
-95.5%
Q4 2020$99,000
+2.1%
6,8110.0%0.04%
+15.8%
Q3 2020$97,000
-3.0%
6,8110.0%0.04%
-11.6%
Q2 2020$100,000
+257.1%
6,8110.0%0.04%
+207.1%
Q1 2020$28,000
-15.2%
6,8110.0%0.01%
+7.7%
Q4 2019$33,000
-19.5%
6,8110.0%0.01%
-27.8%
Q3 2019$41,000
-6.8%
6,8110.0%0.02%
-10.0%
Q2 2019$44,000
-8.3%
6,8110.0%0.02%
-4.8%
Q1 2019$48,000
+45.5%
6,8110.0%0.02%
+31.2%
Q4 2018$33,000
-34.0%
6,8110.0%0.02%
-23.8%
Q3 2018$50,000
+16.3%
6,8110.0%0.02%
+10.5%
Q2 2018$43,000
+16.2%
6,8110.0%0.02%
+11.8%
Q1 2018$37,000
+32.1%
6,8110.0%0.02%
+41.7%
Q4 2017$28,000
-57.6%
6,8110.0%0.01%
-62.5%
Q3 2017$66,000
-20.5%
6,811
-2.8%
0.03%
-23.8%
Q2 2017$83,000
-7.8%
7,0090.0%0.04%
-10.6%
Q1 2017$90,000
+4.7%
7,0090.0%0.05%
+4.4%
Q4 2016$86,000
+3.6%
7,0090.0%0.04%0.0%
Q3 2016$83,000
+36.1%
7,0090.0%0.04%
+32.4%
Q2 2016$61,000
+45.2%
7,009
-12.7%
0.03%
+47.8%
Q1 2016$42,000
-32.3%
8,0280.0%0.02%
-34.3%
Q4 2015$62,000
-1.6%
8,0280.0%0.04%
-7.9%
Q3 2015$63,000
+14.5%
8,028
+33.2%
0.04%
+22.6%
Q2 2015$55,000
-31.2%
6,028
-1.8%
0.03%
-38.0%
Q1 2015$80,000
-2.4%
6,138
+1.8%
0.05%
-2.0%
Q4 2014$82,000
+51.9%
6,0280.0%0.05%
+50.0%
Q3 2014$54,000
-34.1%
6,0280.0%0.03%
-30.6%
Q2 2014$82,000
+36.7%
6,0280.0%0.05%
+25.6%
Q1 2014$60,000
-25.0%
6,0280.0%0.04%
-22.0%
Q4 2013$80,000
+9.6%
6,0280.0%0.05%
-9.1%
Q3 2013$73,000
+17.7%
6,0280.0%0.06%
+17.0%
Q2 2013$62,000
-20.5%
6,0280.0%0.05%
-45.3%
Q1 2013$78,000
+44.4%
6,0280.0%0.09%
+32.3%
Q4 2012$54,0006,0280.06%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,500,000$25,725,0003.13%
CADIAN CAPITAL MANAGEMENT, LP 3,830,399$28,153,0001.28%
Mesirow Financial Investment Management, Inc. 33,001$243,0001.25%
Bellevue Group AG 1,339,502$9,845,0000.62%
NEEDHAM INVESTMENT MANAGEMENT LLC 260,000$1,912,0000.58%
Lyon Street Capital, LLC 109,850$807,0000.50%
Private Wealth Partners, LLC 300,000$2,205,0000.34%
Penn Capital Management Company, LLC 455,064$3,345,0000.25%
HighTower Advisors, LLC 2,337,132$17,179,0000.12%
Schonfeld Strategic Advisors LLC 376,000$2,763,0000.12%
View complete list of GENMARK DIAGNOSTICS INC shareholders